
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65580 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Ranitidine Hydrochloride
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormula:C13H22N4O3S·HClColor and Shape:White Pale Yellow PowderMolecular weight:350.11794Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderCarvedilol
CAS:Cardiovascular drugs, nesoiFormula:C24H26N2O4Color and Shape:White Off-White Crystalline PowderMolecular weight:406.18926Omeprazole Magnesium
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H36MgN6O6S2Color and Shape:White Off-White PowderMolecular weight:712.19882Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C25H37NO3Color and Shape:White Off-White SolidMolecular weight:399.27734Sunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS:Lactams, nesoiFormula:C16H14FN3O2Color and Shape:Pale Yellow Yellow PowderMolecular weight:299.107Omeprazole Related Compound F and G Mixture
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormula:C16H13N3O2SColor and Shape:Dark Brown PowderMolecular weight:311.07285S-Levetiracetam Hydroxybutyramide Analog ((S)-N-(1-amino-1-oxobutan-2-yl)-4-hydroxybutanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H16N2O3Color and Shape:White Off-White SolidMolecular weight:188.11609Rotigotine Related Compound G ((S)-6-{Bis[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H25NOS2·HClColor and Shape:Off-White SolidMolecular weight:419.11443Aminoethyl Fluvoxamine Dihydrochloride ((E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-{2-[(2-aminoethyl)amino]ethyl}oxime dihydrochloride)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C17H26F3N3O2·2HClColor and Shape:White PowderMolecular weight:433.15107Gefitinib
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H24ClFN4O3Color and Shape:White PowderMolecular weight:446.1521Desmethoxyomeprazole
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H17N3O2SColor and Shape:Light Brown Grey Yellow PowderMolecular weight:315.10415Rivaroxaban Related Compound J
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C38H36Cl2N6O10S2Color and Shape:Off-White PowderMolecular weight:870.13114Metoprolol Related Compound D ((+/-)N,N-bis-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl](1-methylethyl)amine hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C27H41NO6·HClColor and Shape:White PowderMolecular weight:475.29339Metoprolol Fumarate
CAS:Aromatic drugs of amino-alcohols, other than those contFormula:C34H54N2O10Color and Shape:White Off-White Crystalline PowderMolecular weight:650.8Monoiodoamiodarone ((2-Butylbenzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3-iodophenyl}methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H30INO3Color and Shape:Colorless Semi-SolidMolecular weight:519.12704Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFormula:C14H14O3Color and Shape:PowderMolecular weight:230.094292-Vinylpyridine (2-Ethenylpyridine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C7H7NColor and Shape:Light Brown LiquidMolecular weight:105.14 g/molPhenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C23H33NO4Color and Shape:White Off-White SolidMolecular weight:387.24096Nadolol Related Compound F (1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C17H23NO2Color and Shape:Off-White SolidMolecular weight:273.17288Carbomer Homopolymer
CAS:Other acrylic polymers in primary forms (excluding elastomeric)Color and Shape:White PowderRotigotine ((S)-6-{Propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSColor and Shape:White Beige PowderMolecular weight:315.16569Oxcarbazepine Related Compound E (10(11H)-Oxo-5H-dibenz[b,f]azepine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C14H11NOColor and Shape:PowderMolecular weight:209.08406Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H12N2O2Color and Shape:White PowderMolecular weight:216.08988Darunavir System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:PowderApremilast R-Enantiomer
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C22H24N2O7SColor and Shape:White Off-White PowderMolecular weight:460.13042Bis((R)-butyramide) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H17N3O2Color and Shape:White Off-White PowderMolecular weight:187.13208Methyl Alcohol
CAS:Methanol (methyl alcohol)Formula:CH4OColor and Shape:Colorless Clear LiquidMolecular weight:32.02621Paliperidone
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H27FN4O3Color and Shape:White PowderMolecular weight:426.206725-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C6H6O3Color and Shape:Yellow SolidMolecular weight:126.03169Desthiophenerivaroxaban Methylcarbamate Analog (methyl ((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H19N3O6Color and Shape:White Off-White SolidMolecular weight:349.12739Metoprolol Succinate
CAS:Aromatic drugs of amino-alcohols, other than those contg > one kind of oxygen function, their ethers and esters; salts thereof, nesoiFormula:(C15H25NO3)2·C4H6O4Color and Shape:White Off-White PowderMolecular weight:534.36689Regorafenib Related Compound A (4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C13H12FN3O2Color and Shape:Brown Violet PowderMolecular weight:261.09135Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFormula:C26H25N5O5Color and Shape:White Off-White PowderMolecular weight:487.18557Paliperidone Related Compound E (3-{2-[4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-7,8-dihydro-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione trifluoroacetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C23H25FN4O3·C2HF3O2Color and Shape:Yellow PowderMolecular weight:424.19107Nadolol Related Compound G (1-(tert-Butylamino)-3-(5,6,7,8-tetrahydronaphthalen-1-yloxy)propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C17H27NO2Color and Shape:Off-White PowderMolecular weight:277.20418Dehydroargatroban Trifluoroacetate ((2R,4R)-4-Methyl-1-{[(3-methylquinolin-8-yl)sulfonyl]-L-arginyl}piperidine-2-carboxylic acid Trifluoroacetate)
Sulfonamides, nesoiFormula:C23H32N6O5S·C2HF3O2Color and Shape:Off-White PowderMolecular weight:504.21549Plerixafor System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White Off-White SolidCrospovidone
CAS:Other vinyl polymers in primary forms,nesoiFormula:(C6H9NO)nColor and Shape:White Off-White PowderMolecular weight:177.121Clioquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C9H5ClINOColor and Shape:PowderMolecular weight:304.91044Sucralose
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFormula:C12H19Cl3O8Color and Shape:White Off-White Crystalline PowderMolecular weight:396.01455Atazanavir System Suitability Mixture (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer)
Compounds containing an unfused pyridine ring in the structure, nesoiColor and Shape:White Light Yellow Crystalline PowderSildenafil Citrate
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C22H30N6O4S·C6H8O7Color and Shape:White Off-White Crystalline PowderMolecular weight:474.20492Polyvinyl Alcohol
CAS:Polyvinyl alcohols, whether or not containing unhydrolyzed acetate groupsFormula:H(C2H4O)m(C4H6O2)nHColor and Shape:PowderMolecular weight:46.0684Dasatinib Related Compound B (N-(2-Chloro-6-methylphenyl)-2-{[2-methyl-6-(piperazin-1-yl)pyrimidin-4-yl]amino}thiazole-5-carboxamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C20H22ClN7OSColor and Shape:White Off-White PowderMolecular weight:443.12951Rivaroxaban Open Chain Dithiophene Analog ((S)-5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-(methylamino)-2-oxoethoxy)ethyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C25H24Cl2N4O6S2Color and Shape:White Off-White SolidMolecular weight:610.05143Mirabegron Racemate
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C21H24N4O2SColor and Shape:White PowderMolecular weight:396.162Nadolol
CAS:Aromatic drugs of amino-alcohols, other than those contFormula:C17H27NO4Color and Shape:White PowderMolecular weight:309.4 g/molParoxetine Methoxy (3R,4S)-Enantiomer Hydrochloride ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H23NO4·HClColor and Shape:White Off-White SolidMolecular weight:341.16271Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H2Cl2O2SColor and Shape:White Off-White SolidMolecular weight:195.91526Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate)
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C25H32F2O5SColor and Shape:White Off-White PowderMolecular weight:482.19385Metoprolol Related Compound A ((+/-)1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]-propan-2-ol)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormula:C14H23NO3Color and Shape:White Clumpy PowderMolecular weight:253.167793-Chlorobenzoic Acid
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormula:C7H5ClO2Color and Shape:White PowderMolecular weight:155.99781O-Desmethyl Apremilast ((S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C21H22N2O7SColor and Shape:Pale Yellow SolidMolecular weight:446.11477Fluconazole
CAS:Anti-infective agents, nesoiFormula:C13H12F2N6OColor and Shape:White Off-White PowderMolecular weight:306.10407Methylisoindolinedione (2-methylisoindoline-1,3-dione)
CAS:Imides and their derivatives (excluding sacharin), and salts thereofFormula:C9H7NO2Color and Shape:White Off-White SolidMolecular weight:161.04768Desiodoamiodarone ((2-butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)phenyl)methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C25H31NO3Color and Shape:Colorless LiquidMolecular weight:393.23039Desimidazoline Sunitinib (5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C14H23N3O2Color and Shape:White Off-White PowderMolecular weight:265.17903Silodosin S-Enantiomer
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C25H32F3N3O4Color and Shape:White Off-White Crystalline PowderMolecular weight:495.23449Atazanavir Sulfate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C38H52N6O7·H2SO4Color and Shape:White Pale Yellow PowderMolecular weight:802.357132-Pyridineethanol (2-(Pyridin-2-yl)ethanol)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C7H9NOColor and Shape:Brown LiquidMolecular weight:123.06841Norepinephrine Bitartrate
CAS:Catecholamine hormones (excluding epinephrine), their derivatives and structural analoguesFormula:C8H11NO3·C4H6O6·H2OColor and Shape:White Light Grey Crystalline PowderMolecular weight:337.1009Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C24H21Cl2N3O7S2Color and Shape:Off-White SolidMolecular weight:597.0198Dofetilide
CAS:Sulfonamides used as drugsFormula:C19H27N3O5S2Color and Shape:White Off-White Crystalline PowderMolecular weight:441.13921Carvedilol Bisalkylpyrocatechol derivative (3,3'-{2,2'-[1,2-Phenylenebis(oxy)]bis(ethane-2,1-diyl)}bis(azanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C40H42N4O6Color and Shape:Off-White Light Brown SolidMolecular weight:674.31044Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13NOColor and Shape:White Powder ClumpyMolecular weight:199.099714-(Pyridin-2-yl)benzaldehyde (4-(Pyridin-2-yl)benzaldehyde)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C12H9NOColor and Shape:Pale Yellow Off-White PowderMolecular weight:183.06841Duloxetine Related Compound A ((R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:Off-White SolidMolecular weight:297.11874Carvedilol Related Compound D (4-(Oxiran-2-ylmethoxy)-9H-carbazole)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormula:C15H13NO2Color and Shape:Light Yellow PowderMolecular weight:239.09463Alcohol Determination - Alcohol
CAS:Other spirituous beverages, nesoiFormula:C2H6OColor and Shape:Colorless Translucent LiquidMolecular weight:46.04186Nadolol Related Compound B ((2RS,3SR)-5-(2-Hydroxy-3-methoxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C14H20O5Color and Shape:White SolidMolecular weight:268.13107Nadolol Related Compound A ((2RS,3SR)-5-(2,3-Dihydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol)
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C13H18O5Color and Shape:White SolidMolecular weight:254.11542Celecoxib Open Ring (4-((1,1,1-trifluoro-4-hydroxy-4-(p-tolyl)but-3-en-2-ylidene)amino)benzenesulfonamide)
Sulfonamides, nesoiFormula:C17H15F3N2O3SColor and Shape:Yellow SolidMolecular weight:384.07555Ambrisentan
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C22H22N2O4Color and Shape:White Light Yellow Crystalline PowderMolecular weight:378.15796Norepinephrine Related Compound D ((R)-4-(2-Amino-1-methoxyethyl)benzene-1,2-diol bitartrate hydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C9H13NO3·C4H6O6·H2OColor and Shape:Light Brown Off-White SolidMolecular weight:183.08954Dabigatran Etexilate Related Compound A (Ethyl 3-(2-{[(4-{[(hexyloxy)carbonyl]carbamoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H40N6O6Color and Shape:White SolidMolecular weight:628.30093Plerixafor
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C28H54N8Color and Shape:White Off-White PowderMolecular weight:502.44714Amiodarone Related Compound H (2-chloro-N,N-diethylethanamine hydrochloride)
CAS:3-amino-3-methyl-1-butyne;2-chloro-n,n-dimethyl-ethylamine hydrochloride; 2-(diethylamino) isopropyl chloride hydrochlorideFormula:C6H14ClN·ClHColor and Shape:Off-White PowderMolecular weight:171.05815Brivaracetam Related Compound A ((S)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS:Lactams, nesoiFormula:C11H20N2O2Color and Shape:White PowderMolecular weight:212.15248Rivaroxaban R-enantiomer ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H18ClN3O5SColor and Shape:Yellow White SolidMolecular weight:435.06557Fluphenazine Hydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C22H26F3N3OS·2ClHColor and Shape:White Off-White Crystalline PowderMolecular weight:509.12822N-Nitroso Dabigatran Etexilate Solution (1 mL ) (ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H40N8O6Color and Shape:Colorless LiquidMolecular weight:656.30708Aripiprazole Hydroxydihydroquinolinone Analog (7-hydroxy-3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C9H9NO2Color and Shape:White Off-White SolidMolecular weight:163.06333Brivaracetam Related Compound D ((S)-2-[(R)-2-Oxo-4-propylpyrrolidin-1-yl]butanoic acid)
CAS:Lactams, nesoiFormula:C11H19NO3Color and Shape:White Off-White Fine PowderMolecular weight:213.13649Desmethoxy Fluvoxamine Maleate ((E)-1-[4-(Trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime maleate)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormula:C14H19F3N2O·C4H4O4Color and Shape:White PowderMolecular weight:288.14495Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C22H20N4O6Color and Shape:Light Brown PowderMolecular weight:436.13828Rivaroxaban isomer (4-(4-(((2-(5-chlorothiophen-2-yl)-4,5-dihydrooxazol-5-yl)methyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H18ClN3O3SColor and Shape:White Off-White SolidMolecular weight:391.07574Apremilast Desphthalyl Amine ((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C12H19NO4SColor and Shape:White Off-White SolidMolecular weight:273.10348Salmeterol Xinafoate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFormula:C25H37NO4·C11H8O3Color and Shape:White PowderMolecular weight:415.27226Fluconazole Diol (2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propane-1,2-diol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C11H11F2N3O2Color and Shape:White SolidMolecular weight:255.08193Fluconazole Related Compound A (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C15H14FN9OColor and Shape:White PowderMolecular weight:355.13053Anhydrous Lactose (A Mixture of α and β anomers)
CAS:Lactose and lactose syrup, containing by weight 99% or more lactose, expressed as anhydrous lactose, calculated on the dry matterFormula:C12H22O11Color and Shape:White Off-White PowderMolecular weight:342.11621Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C32H30N4O8Color and Shape:Pale Yellow SolidMolecular weight:598.20636Rivaroxaban Related Compound B ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H19N3O5Color and Shape:White Off-White SolidMolecular weight:333.13247Metoprolol Related Compound B ((+/-)1-Chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]-propane)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H17ClO3Color and Shape:Pale Yellow Clear LiquidMolecular weight:244.08662Iodoquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C9H5I2NOColor and Shape:Light Brown Yellow PowderMolecular weight:396.84606Dibenzazepinodione (5H-dibenzo[b,f]azepine-10,11-dione)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C14H9NO2Color and Shape:Dark Orange SolidMolecular weight:223.06333Methoxyethyl Phenol
CAS:Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormula:C9H12O2Color and Shape:White PowderMolecular weight:152.08373Ambrisentan Related Compound C (2-[(4,6-Dimethylpyrimidin-2-yl)oxy]-3-hydroxy-3,3-diphenylpropanoic acid)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C21H20N2O4Color and Shape:White Off-White SolidMolecular weight:364.14231Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS:Nitrile function compounds, not elsewhere specified or includedFormula:C12H9F3N2O2Color and Shape:White Off-White PowderMolecular weight:270.06161Rivaroxaban Phthalimide ((S)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H21N3O5Color and Shape:White Off-White SolidMolecular weight:395.14812Sorafenib Related Compound H (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H16ClF3N4O3Color and Shape:Pale Yellow SolidMolecular weight:464.0863N-Nitroso Metoprolol Solution (1 mL ) (N-(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)-N-isopropylnitrous amide)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFormula:C15H24N2O4Color and Shape:Colorless LiquidMolecular weight:296.17361Sorafenib Formamide (4-(4-formamidophenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C14H13N3O3Color and Shape:Off-White SolidMolecular weight:271.09569Levetiracetam Crotonamide ((Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide)
CAS:Lactams, nesoiFormula:C8H12N2O2Color and Shape:White Off-White SolidMolecular weight:168.08988Norepinephrine Related Compound E (2-Chloro-1-(3,4-dihydroxyphenyl)ethan-1-one)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormula:C8H7ClO3Color and Shape:Dark Grey PowderMolecular weight:186.00837Rivaroxaban phthalimido ethyl ester analog ((S)-1-(1,3-dioxoisoindolin-2-yl)-3-((ethoxycarbonyl)(4-(3-oxomorpholino)phenyl)amino)propan-2-yl 5-chlorothiophene-2-carboxylate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C29H26ClN3O8SColor and Shape:White Off-White SolidMolecular weight:611.11291Dofetilide Related Compound A (N-[4-(2-{2-[4-(Methanesulfonamido)phenoxy]ethylamino}ethyl)phenyl]methanesulfonamide)
CAS:Sulfonamides, nesoiFormula:C18H25N3O5S2Color and Shape:White PowderMolecular weight:427.12356Benzyl Alcohol
CAS:Benzyl alcohol (alpha-hydroxytoluene; phenyl-methanol)Formula:C7H8OColor and Shape:Colorless Clear LiquidMolecular weight:108.14 g/molAlcohol
CAS:Ethyl alcohol, undenatured, of an alcoholic strength by volume of 80 percent vol. or higher, for nonbeverage purposes, excluding for fuel useFormula:C2H6OColor and Shape:Clear Colorless LiquidMolecular weight:46.075-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C5H5NO3Color and Shape:White SolidMolecular weight:127.02694Fesoterodine Chloromandelate
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C26H37NO3·C8H7ClO3Color and Shape:White Fine PowderMolecular weight:411.27734Sunitinib Malate
CAS:Lactams not elsewhere specified or includedFormula:C22H27FN4O2·C4H6O5Color and Shape:Yellow Orange PowderMolecular weight:532.23333Levetiracetam
CAS:Lactams, nesoiFormula:C8H14N2O2Color and Shape:White PowderMolecular weight:170.10553Sorafenib Tosylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H16ClF3N4O3·C7H8O3SColor and Shape:White Brown PowderMolecular weight:636.10572Levetiracetam Related Compound B ((S)-2-aminobutanamide hydrochloride)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C4H10N2O·HClColor and Shape:White Cream PowderMolecular weight:102.07931Silodosin
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C25H32F3N3O4Color and Shape:White Pale Yellow Crystalline PowderMolecular weight:495.23449Naproxen Related Compound K (1-(6-Methoxynaphthalen-2-yl)ethanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C13H14O2Color and Shape:White Crystalline PowderMolecular weight:202.09938Methoxy Carbamazepine (10-Methoxy-5H-dibenz[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H14N2O2Color and Shape:White Off-White SolidMolecular weight:266.10553Saxagliptin
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C18H25N3O2·H2OColor and Shape:White Off-White Light Brown Crystalline PowderMolecular weight:333.20524Oxcarbazepine Related Compound D (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C30H22N4O3Color and Shape:Light Yellow Yellow PowderMolecular weight:486.16919Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C27H29BrN4O5Color and Shape:Cream PowderMolecular weight:568.13213Omeprazole Related Compound C (5-Methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylthio]-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C17H19N3O2SColor and Shape:White Off-White PowderMolecular weight:329.1198Fluphenazine Enanthate Dihydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C29H38F3N3O2S·2HClColor and Shape:PowderMolecular weight:549.26368Regorafenib
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H15ClF4N4O3·H2OColor and Shape:White Brown PowderMolecular weight:500.08745Rivaroxaban Phthalimido Analog ((R)-2-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl) isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C21H21N3O5Color and Shape:White Off-White SolidMolecular weight:395.14812Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C14H21N3O3Color and Shape:White Off-White SolidMolecular weight:279.15829o-Celecoxib (4-(5-(o-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White Off-White SolidMolecular weight:381.07588Naproxen Related Compound E ((S)-Methyl 2-(6-methoxynaphthalen-2-yl)propanoate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C15H16O3Color and Shape:White Crystalline PowderMolecular weight:244.10994Imidazole (1H-Imidazole)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C3H4N2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:68.03745Ambrisentan Related Compound E (4,6-Dimethylpyrimidin-2-ol)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C6H8N2OColor and Shape:White Off-White Pale Yellow Crystalline PowderMolecular weight:124.06366Oxcarbazepine Related Compound C (Acridin-9(10H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFormula:C13H9NOColor and Shape:Yellow Green SolidMolecular weight:195.06841Sorafenib Diarylurea Analog (4,4'-[carbonylbis(azanediyl-4,1-phenyleneoxy)]bis(N-methylpyridine-2-carboxamide);N,N'-Bis{4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl}urea)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H24N6O5Color and Shape:White Off-White SolidMolecular weight:512.18082Rivaroxaban Glycolic Acid Analog ((S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)amino)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20ClN3O6SColor and Shape:Pale Yellow SolidMolecular weight:453.07613Metoprolol Dimer (1,3-Bis[4-(2-methoxyethyl)phenoxy]propan-2-ol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C21H28O5Color and Shape:Colorless Light Yellow LiquidMolecular weight:360.19367Deschlorosorafenib (N-Methyl-4-[4-[[[[3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-2-pyridinecarboxamide; N-Methyl-4-{4-[3-(3-trifluoromethylphenyl)ureido]phenoxy}picolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H17F3N4O3Color and Shape:White Off-White SolidMolecular weight:430.12527Brivaracetam Related Compound B ((R)-2-[(S)-2-Oxo-4-propylpyrrolidin-1-yl]butanamide)
CAS:Lactams, nesoiFormula:C11H20N2O2Color and Shape:White Off-White SolidMolecular weight:212.15248Clioquinol Related Compound B (5,7-Dichloroquinolin-8-ol)
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C9H5Cl2NOColor and Shape:White Off-White PowderMolecular weight:212.97482Duloxetine Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H19NOS·HClColor and Shape:White Off-White PowderMolecular weight:297.11874Paroxetine Related Compound E (4-(4-Fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine hydrochloride)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C12H14FN·HClColor and Shape:White PowderMolecular weight:191.11103Fluphenazine Decanoate Dihydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFormula:C32H44F3N3O2S·2HClColor and Shape:White PowderMolecular weight:663.26399Rivaroxaban Related Compound H ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H17Cl2N3O5SColor and Shape:Yellow PowderMolecular weight:469.0266Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C25H37NO4Color and Shape:Off-White Crystalline PowderMolecular weight:415.27226Omeprazole Related Compound B (5-Methoxy-1H-benzimidazol-2-thiol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C8H8N2OSColor and Shape:White Off-White PowderMolecular weight:180.03573Fluvoxketone (5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one)
CAS:Ketones and quinones, w/not with other oxygen function,and their halogenated,sulfated,nitrated,or nitrosated derivatives, nesoiFormula:C13H15F3O2Color and Shape:White PowderMolecular weight:260.10241Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C23H32N6O4SColor and Shape:White PowderMolecular weight:488.22057Topiramate
CAS:Sulfonamides used as drugsFormula:C12H21NO8SColor and Shape:White Off-White Crystalline PowderMolecular weight:339.09879Atazanavir Related Compound A ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H15NO4Color and Shape:Off-White White Powder ClumpyMolecular weight:189.10011Clozapine Benzoyl Methylpiperazine Analog (1-[2-[(2-Amino-4-chlorophenyl)amino]benzoyl]-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C18H21ClN4OColor and Shape:Beige PowderMolecular weight:344.14039Paroxetine Related Compound C ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H20FNO3·HClColor and Shape:White PowderMolecular weight:365.1194Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:Sulfonamides, nesoiFormula:C19H27N3O6S2Color and Shape:Off-White PowderMolecular weight:457.13413Ondansetron Related Compound G (3-[(1H-Imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C17H17N3OColor and Shape:White PowderMolecular weight:279.13716Rotigotine Related Compound H ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H27NOSColor and Shape:Light Brown LiquidMolecular weight:329.18134Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H25NOSHClColor and Shape:White Off-White PowderMolecular weight:315.165693-Acetamidophthalic acid (3-acetamidophthalic acid)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormula:C10H9NO5Color and Shape:Off-White SolidMolecular weight:223.04807Apremilast Open Ring 3-acetamide ((S)-3-acetamido-2-((1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)carbamoyl)benzoic acid)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C22H26N2O8SColor and Shape:Off-White SolidMolecular weight:478.14099Apremilast
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C22H24N2O7SMolecular weight:460.13042Metoprolol Related Compound E (3-[4-(2-Methoxyethyl)phenoxy]propane-1,2-diol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormula:C12H18O4Color and Shape:White Coarse Powder Semi-SolidMolecular weight:226.12051Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H18ClNO·HClColor and Shape:White PowderMolecular weight:275.08437Bupropion Hydrochloride Related Compound F (1-(3-chlorophenyl)-1-hydroxypropan-2-one)
CAS:Aromatic ketone-alcohols and ketone-aldehydes, nesoiFormula:C9H9ClO2Color and Shape:Clear Yellow LiquidMolecular weight:184.029115-Chloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-(3,5-dichlorophenyl)propan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H17Cl2NO·HClColor and Shape:White PowderMolecular weight:309.0454Amiodarone Related Compound D ((2-Butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C19H16I2O3Color and Shape:White Yellow PowderMolecular weight:545.91889Celecoxib Related Compound A (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFormula:C17H14F3N3O2SColor and Shape:White PowderMolecular weight:381.07588Atazanavir Dipeptide Analog (methyl ((5S,8S,13S,14S,17S)-14-benzyl-5,8-di-tert-butyl-13-hydroxy-18,18-dimethyl-3,6,9,16-tetraoxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,10,11,15-pentaazanonadecan-17-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C44H63N7O8Color and Shape:SolidMolecular weight:817.47381Bupropion Hydrochloride Related Compound B (2-(tert-butylamino)-3'-bromopropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H18BrNO·HClColor and Shape:Off-White PowderMolecular weight:319.03385Aripiprazole Related Compound G (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C23H25Cl2N3O2Color and Shape:White Light Yellow Crystalline PowderMolecular weight:445.13238N-Nitroso Bupropion Solution (1 mL ) (N-(tert-butyl)-N-(1-(3-chlorophenyl)-1-oxopropan-2-yl) nitrous amide)
CAS:Compounds with other nitrogen function, nesoiFormula:C13H17ClN2O2Color and Shape:LiquidMolecular weight:268.09786Aripiprazole 4,4'-dimer (7,7'-((((ethane-1,1-diylbis(2,3-dichloro-4,1-phenylene))bis(piperazine-4,1-diyl))bis(butane-4,1-diyl))bis(oxy))bis(3,4-dihydroquinolin-2(1H)-one)
CAS:Lactams, nesoiFormula:C48H56Cl4N6O4Color and Shape:White Off-White SolidMolecular weight:920.31172Hydroxybenzoyl Paliperidone (3-(2-(4-(4-fluoro-2-hydroxybenzoyl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C23H28FN3O4Color and Shape:Off-White SolidMolecular weight:429.20638Gefitinib Related Compound B (N-(4-Chloro-3-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H24ClFN4O3Color and Shape:Light Yellow PowderMolecular weight:446.1521Desthiophenerivaroxaban Phthalimodo Analog ((R)-2-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.12739Desethylamiodarone (2-Butyl-3-benzofuranyl-4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl Ketone Hydrochloride)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C23H25I2NO3·HClColor and Shape:White Off-White SolidMolecular weight:652.96907Saxagliptin Related Compound B (Saxagliptin amide analog (1S,3S,5S)-2-{(S)-2-Amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormula:C18H27N3O3Color and Shape:White Fine PowderMolecular weight:333.20524Nilotinib Related Compound C (3-Amino-4-methylbenzoic acid)
CAS:Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, not elsewhere specified or includedFormula:C8H9NO2Color and Shape:White Beige PowderMolecular weight:151.06333Oxcarbazepine Related Compound B (N-Acetyl-10-oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C17H14N2O3Color and Shape:White Yellow PowderMolecular weight:294.10044Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormula:C36H43NO6·H2OColor and Shape:White SolidMolecular weight:603.3196Teriflunomide
CAS:Nitrile function compounds, nesoiFormula:C12H9F3N2O2Color and Shape:White Crystalline PowderMolecular weight:270.06161Mirabegron
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C21H24N4O2SColor and Shape:White Off-White Brownish Yellow Crystalline PowderMolecular weight:396.162Sodium Starch Glycolate Type B
CAS:Dextrins, nesoiFormula:C2H4O3·xNa·xUnspecifiedColor and Shape:Off-White White PowderMolecular weight:515.6862Topiramate Related Compound A (2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose)
CAS:Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C12H20O6Color and Shape:White PowderMolecular weight:260.125992,4-Disulfamyl-5-Trifluoromethylaniline
CAS:Sulfonamides, nesoiFormula:C7H8F3N3O4S2Color and Shape:PowderMolecular weight:318.99083Sodium Starch Glycolate Type A
CAS:Modified starches, nesoiFormula:(C2H4O3)x·(Na)xColor and Shape:White Off-White PowderMolecular weight:515.6862Saxagliptin Related Compound C ((1aS,4S,6aR,7aS)-4-[(1r,3R,5R,7S)-3-Hydroxyadamantan-1-yl]hexahydro-1H-cyclopropa[4,5]pyrrolo[1,2-a]pyrazine-3,6-dione)
CAS:Lactams, nesoiFormula:C18H24N2O3Color and Shape:White PowderMolecular weight:316.17869Prasugrel Hydrochloride (5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C20H20FNO3S·HClColor and Shape:White Off-White PowderMolecular weight:409.09147Ezetimibe System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiColor and Shape:White PowderOfloxacin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C18H20FN3O4Color and Shape:Off-White Pale Yellow PowderMolecular weight:361.14378Hexyl Methanesulfonate
CAS:Hydrocarbon derivatives containing only sulfo groups, their salts andestersFormula:C7H16O3SColor and Shape:Clear Yellow LiquidMolecular weight:180.08202Clozapine Resolution Mixture
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureColor and Shape:Yellow Crystalline PowderMolecular weight:203.09061Desacetyl Apremilast ((S)-4-Amino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Formula:C20H22N2O6SColor and Shape:Yellow PowderMolecular weight:418.11986Amiodarone Related Compound E ((2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormula:C19H18O3Color and Shape:White Brown PowderMolecular weight:294.12559Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C17H18FN3O4Color and Shape:Light Yellow PowderMolecular weight:347.12813Rivaroxaban Ethyl Carbamate (ethyl (4-(3-oxomorpholino)phenyl)carbamate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C13H16N2O4Color and Shape:White Off-White SolidMolecular weight:264.11101Deschloro Bupropion Hydrochloride (2-(tert-Butylamino)-1-phenylpropan-1-one hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFormula:C13H19NO·HClColor and Shape:White PowderMolecular weight:241.12334Paroxetine Related Compound B ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H21NO3·HClColor and Shape:White PowderMolecular weight:347.84Atazanavir Formyl Analog (methyl ((S)-1-(((2S,3S)-4-(2-((S)-2-formamido-3,3-dimethylbutanoyl)-1-(4-(pyridin-2-yl)benzyl)hydrazinyl)-3-hydroxy-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C37H50N6O6Color and Shape:Off-White SolidMolecular weight:674.37918Aminophenylmorpholin-2-one (4-(4-aminophenyl)morpholin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C10H12N2O2Color and Shape:Pale Yellow SolidMolecular weight:192.08988Alectinib Hydrochloride
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C30H34N4O2·HClMolecular weight:482.26818Naproxen Related Compound A (6-methoxy-2-naphthoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFormula:C12H10O3Color and Shape:White Off-White PowderMolecular weight:202.06299Clioquinol Related Compound A (5-Chloroquinolin-8-ol)
CAS:Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormula:C9H6ClNOColor and Shape:Off-White PowderMolecular weight:179.01379

